Twelve-Month Results of a Single or Multiple Dexamethasone Intravitreal Implant for Macular Edema following Uncomplicated Phacoemulsification
Table 2
Central foveal thickness (CFT) prior to treatment and at follow-up intervals.
Patient
Baseline
Day 7
Mo. 1
Mo. 2
Mo. 4
Mo. 6
Mo. 8
Mo. 12
1
563
349
349
346
345
339
340
346
2
438
381
266
256
250
255
251
248
3
852
361
221
220
—
—
—
—
4
707
395
223
215
260
470
—
—
5
658
263
254
201
213
213
210
215
6*
630
312
279
266
295
309
250
369
7*
424
297
269
289
268
277
250
261
8*
808
397
270
263
278
280
273
268
9*
610
369
302
289
285
298
281
303
10*
526
331
305
289
290
293
282
249
Mean
621.6
345.5
273.8
263.4
276
303.8
267.1
282.4
Median
620
355
269.5
264.5
278
293
262
264.5
SD
142.2
44.3
38.5
43.4
36.0
71.5
37.5
52.7
Range
424–852
263–397
221–349
201–346
213–345
213–470
210–340
215–369
value†
0.005
0.005
0.005
0.008
0.008
0.012
0.012
Delta‡
−276
−348
−358
−346
−318
−354
−339
Patients denoted with had a second implant at month 7. Patients dropped out from the study. † value refers to Wilcoxon signed-rank test on the median values with respect to the baseline. ‡Delta denotes the mean difference with the baseline. Mo.: month.